RFHVMn ORF73 is structurally related to the KSHV ORF73 latency-associated nuclear antigen (LANA) and is expressed in retroperitoneal fibromatosis (RF) tumor cells  by Burnside, Kellie L. et al.
6) 103–115
www.elsevier.com/locate/yviroVirology 354 (200RFHVMn ORF73 is structurally related to the KSHV ORF73
latency-associated nuclear antigen (LANA) and is expressed in
retroperitoneal fibromatosis (RF) tumor cells
Kellie L. Burnside a, Jonathan T. Ryan a, Helle Bielefeldt-Ohmann b,1, A. Gregory Bruce a,
Margaret E. Thouless a, Che-Chung Tsai b, Timothy M. Rose a,⁎
a Department of Pathobiology, School of Public Health and Community Medicine, HSB Rm F161E, Box 357238,
University of Washington, Seattle, WA 98195, USA
b Washington National Primate Research Center, University of Washington, Seattle, WA 98195, USA
Received 9 March 2006; returned to author for revision 11 April 2006; accepted 15 June 2006
Available online 1 August 2006Abstract
Retroperitoneal fibromatosis herpesvirus (RFHV), the macaque homolog of the human rhadinovirus, Kaposi's sarcoma-associated herpesvirus
(KSHV), was first identified in retroperitoneal fibromatosis (RF) tumor lesions of macaques with simian AIDS. We cloned and sequenced the
ORF73 latency-associated nuclear antigen (LANA) of RFHVMn from the pig-tailed macaque. RFHVMn LANA is structurally analogous to
KSHV ORF73 LANA and contains an N-terminal serine–proline-rich region, a large internal glutamic acidic-rich repeat region and a conserved
C-terminal domain. RFHVMn LANA reacts with monoclonal antibodies specific for a glutamic acid–proline dipeptide motif and a glutamic acid–
glutamine-rich motif in the KSHV LANA repeat region. Immunohistochemical and immunofluorescence analysis revealed that RFHVMn LANA
is a nuclear antigen which is highly expressed in RF spindloid tumor cells. These data suggest that RFHV LANA is an ortholog of KSHV LANA
and will function similarly to maintain viral latency and play a role in tumorigenicity in macaques.
© 2006 Elsevier Inc. All rights reserved.Keywords: LANA; Latency associated; Retroperitoneal fibromatosis; Rhadinovirus; ORF73; KSHV; RFHV; Kaposi's sarcomaIntroduction
Kaposi's sarcoma-associated herpesvirus (KSHV)/human
herpesvirus 8 was first discovered in AIDS patients in
association with Kaposi's sarcoma (KS) (Chang et al., 1994)
and has been linked with other AIDS-related malignancies, such
as primary effusion lymphomas (PEL) and multicentric
Castleman's disease (Cesarman et al., 1995; Soulier et al.,
1995). Analysis of the KSHV genome revealed a strong
similarity in sequence and gene organization with herpesvirus
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doi:10.1016/j.virol.2006.06.022gammaherpesviruses found in the New World squirrel monkey
(Russo et al., 1996). KSHV is detected in all epidemiologic
forms of KS, including classical KS, endemic KS, and AIDS-
associated KS, strongly implicating KSHV as the causative
agent of the disease (Verma and Robertson, 2003). Essentially
all of the characteristic spindle-shaped tumor cells in KS lesions
are latently infected with KSHV (Boshoff et al., 1995; Staskus
et al., 1997). KSHV latency is characterized by the expression
of a restricted set of viral proteins that are believed to play
important roles in the maintenance of the viral genome and in
the tumorigenesis process leading to the development of KS
(Sarid et al., 1998).
The most prominent protein expressed in cells latently
infected with KSHV is the orf73 gene product, the latency-
associated nuclear antigen (LANA) (Kedes et al., 1997; Kellam
et al., 1997; Rainbow et al., 1997). KSHV LANA is expressed
from a polycistronic transcript with two other latent genes, K13,
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orf72, encoding the viral cyclin D homolog (v-cycD) (Dittmer
et al., 1998; Glenn et al., 1999). LANA is a nuclear protein that
functions to ensure the maintenance of the viral genome within
the host cell by tethering the viral episomal DNA to host cell
chromosomes (Ballestas et al., 1999). LANA also regulates the
cellular transcription program in KSHV-infected cells through
interaction with a number of cellular proteins, including
transcriptional regulators, such as the mSin3-associated cor-
epressor SAP30, Sp1, and ATF4/CREB2, as well as known
tumor suppressors, p53 and pRB (Friborg et al., 1999; Krithivas
et al., 2000; Radkov et al., 2000). Furthermore, KSHV LANA
directly influences the viral transcription program and helps to
maintain the latent state of the virus by inhibiting viral
replication (Lan et al., 2004).
KSHV LANA is a large polypeptide with three structural
domains (Russo et al., 1996). The serine- and proline-rich N-
terminal domain contains a nuclear localization signal (NLS)
(Piolot et al., 2001), a chromatin-binding motif (CBM) (Wong
et al., 2004) and domains responsible for interaction with the
transcription regulators, mSin3 complex and Sp1 (Krithivas et
al., 2000; Verma et al., 2004). The central domain contains
several highly repetitive acidic regions that vary in length
and are responsible for the size variation of LANA proteins
from different KSHV isolates that can range from 1003 to 1162
amino acids (Gao et al., 1999). The proline-rich C-terminal third
domain contains another NLS and is responsible for dimeriza-
tion of LANA and binding to the terminal repeats (TR) of the
viral genomic DNA (Ballestas et al., 1999; Cotter and
Robertson, 1999; Komatsu et al., 2004). The C-terminal domain
is responsible for interaction with tumor suppressors pRB and
p53 (Friborg et al., 1999; Radkov et al., 2000).
Two distinct lineages of rhadinoviruses related toKSHVhave
been identified in Old World primates. The RV1 rhadinovirus
lineage consists of KSHV and its homologs in different non-
human primate species, including African greenmonkeys, drills,
gorillas, chimpanzees, and macaques (Greensill et al., 2000;
Lacoste et al., 2000a; Lacoste et al., 2000b; Schultz et al., 2000).
The macaque RV1 rhadinovirus, retroperitoneal fibromatosis-
associated herpesvirus (RFHV), is the most fully characterized
of the non-human RV1 rhadinoviruses to date. The complete
sequences for a region of the viral genome containing the DNA
polymerase and four other adjacent genes have been obtained for
two strains of RFHV from different macaque species, Macaca
mulatta (rhesus) (RFHVMm) and Macaca nemestrina (pig-
tailed) (RFHVMn) (Rose et al., 2003). The RV2 rhadinovirus
lineage consists of a group of more distantly related viruses
which co-infect the same Old World primate species (Greensill
et al., 2000; Lacoste et al., 2000b; Schultz et al., 2000; Lacoste et
al., 2001; Whitby et al., 2003). Of this group, the macaque RV2
rhadinoviruses are the most completely characterized. The
complete sequence of the genomes of two strains of the rhesus
macaque RV2 rhadinovirus (RRV) have been determined
(Alexander et al., 2000; Searles et al., 1999), and the
glycoprotein B sequence and a partial sequence of the DNA
polymerase gene are available from the virus found in pig-tailed
macaques (MneRV2/PMRV) (Auerbach et al., 2000; Schultz etal., 2000). The presence of RV1 and RV2 rhadinoviruses in both
OldWorld monkeys and apes suggests that the two viral lineages
have evolved from an ancient non-speciative divergence within
an ancestral primate host.
We first identified the macaque RV1 rhadinovirus, RFHV,
in retroperitoneal fibromatosis and related subcutaneous
fibromatosis lesions of macaques, herein referred to as RF
(Rose et al., 1997). RF is a fibroproliferative neoplasm
associated with simian AIDS (SAIDS) which has strong
similarities to AIDS-KS (Tsai et al., 1990). Like KS, RF
lesions are multifocal with increased vascularity, and contain
tumor cells exhibiting a characteristic spindle-shaped cell
morphology (London et al., 1983; Tsai et al., 1985). We
previously detected the presence of both macaque RV1 and
RV2 rhadinoviruses in RF tumor lesions by PCR (Schultz et
al., 2000; Bielefeldt-Ohmann et al., 2005). In order to study
the biology of these viruses and determine their potential roles
in the development of RF in macaques, we cloned and
sequenced the ORF73 LANA homologs of the RV1 and RV2
rhadinoviruses of the pig-tailed macaque in which the
majority of RF cases within the Washington National Primate
Research Center (WaNPRC) occurred. We show here that
RFHVMn LANA has strong sequence homology to KSHV
LANA and exhibits the same structural domains and
conserved motifs. We prepared recombinant RFHVMn,
MneRV2 and RRV LANA proteins and identified monoclonal
antibodies which specifically react with RFHVMn LANA.
Using these antibodies, we determined that the spindle-shaped
tumor cells within RF lesions are infected with RFHV and
express RFHV LANA as a prominent nuclear antigen
suggesting that it plays a role in the development and/or
maintenance of RF tumors.
Results
Cloning and characterization of ORF 73 LANA of the macaque
RV1 rhadinovirus, RFHVMn
A lambda library was prepared from high molecular
weight DNA obtained from an archived RF tumor sample of
a pig-tailed macaque from the WaNPRC which contained ~1
viral copy/cell of the macaque rhadinovirus, RFHVMn. A
lambda clone was identified which contained 10kb of the
RFHVMn genome, spanning the orf73 gene. Sequence
analysis revealed a large open reading frame of 3213 bp
encoding a 1071-amino-acid protein which showed the
highest similarity with the KSHV LANA in a BLAST search.
This open reading frame was flanked by sequences upstream
and downstream which showed close similarities to ORF72,
K13 and K14 of KSHV indicating that the region of the
RFHVMn genome containing the LANA locus was identical
in structure and gene content to KSHV. Sequence alignment
of the LANA homologs of the RFHVMn and KSHV RV1
rhadinoviruses revealed a close similarity in length and
structure. Like KSHV LANA, RFHVMn LANA contained an
N-terminal region of ∼300 aa and a C-terminal region of
∼225 aa which were separated by an acidic repeat region of
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KSHV LANA (Fig. 1).
Alignment of the N-terminal regions of RFHVMn and
KSHV LANAs revealed two distinguishable subdomains.
The first was a basic amino acid-rich domain just down-
stream of the initiating methionine (aa 1–48, RFHVMn)
which showed significant amino acid conservation between
the RFHVMn and KSHV sequences (39% amino acid
identity) (Fig. 2). Flanking that was a larger region of 279
aa with low sequence similarity (25% identity), primarily
between serine and proline residues (aa 49–335, RFHVMn).
Alignment of the C-terminal regions of the RFHVMn and
KSHV LANA sequences revealed a conserved C-terminal
domain of 223 amino acids (aa 849–1071, RFHVMn) which
showed 54% sequence identity between the RFHVMn and
KSHV sequences.
A comparison of the internal acidic repeat regions of the
RFHVMn and KSHV LANA homologs revealed little
sequence similarity except for the abundant presence of
glutamic acid residues in both sequences. While the 513-
amino-acid acidic repeat region of the RFHVMn LANA
homolog contained ∼57 copies of perfect and imperfect copies
of a single consensus motif, “EEPEPEPE” (Fig. 3B), KSHV
LANA contained four separate repeat domains with consensus
motifs of EEDD/EEED (∼25 repeats), QQQEP/QQREP (∼31
repeats), QQQDE/QEQQDE (∼32 repeats), and QEQELEE/
EEQEEQELEEV (∼21 repeats) (based on the 1162-amino-
acid variant; Fig. 3A). KSHV LANA variants with sizes
ranging from 1003 to 1162 amino acids have been detected
with different numbers of repeats within these domains (Gao et
al., 1999). Analysis of the underlying DNA sequence encoding
the four different KSHV repeats revealed a single consensusFig. 1. Schematic structural comparison of the RFHVMn and MneRV2 ORF73 LAN
World primate rhadinovirus lineage: KSHV (human; NP_572129) and RFHVMn (pi
MneRV2 (pig-tailed macaque; this study), and RRV (rhesus macaque; AAD21406)
AtHV3 (spider monkey; NP_048045), and the murine rhadinovirus: MHV68 (mousDNA sequence element for each repeat that was present a
variable number of times (Fig. 3A). Similarly, a single
consensus DNA sequence encoded the “EEPEPEPE” motif
of RFHVMn LANA (Fig. 3B). No sequence similarity was
detected between the DNA consensus elements of the
RFHVMn and KSHV LANA homologs.
Dot matrix analysis of the DNA and encoded amino acid
sequences of the RFHVMn acidic repeat region revealed the
presence of two larger motifs, each present twice in the domain.
One repeated motif contained three exact consensus elements
and five variant elements (single underline in Fig. 3B), while the
other contained six exact consensus elements (double underline,
Fig. 3B). These results suggest that the RFHVMn repeat motif
has evolved through both short range duplication of the single
“EEPEPEPE” sequence and a long range duplication of
multiple repeats.
Cloning and characterization of the MneRV2 LANA homolog
In order to compare the LANA homologs of RV1 and RV2
rhadinoviruses from the same macaque host species, we cloned
the orf73 gene from the macaque RV2 rhadinovirus, MneRV2,
which like RFHVMn infects the pig-tailed macaque. Sequence
analysis revealed an open reading frame of 1314 nucleotides
which encoded a protein of 438 amino acids. As shown in Figs.
1 and 2, MneRV2 LANAwas similar in structure and length to
the 448-amino-acid LANA homolog of RRV, the closely
related RV2 rhadinovirus infecting rhesus macaques (M.
mulatta) (Alexander et al., 2000; Piolot et al., 2001; Searles
et al., 1999).
Overall, the LANA homologs of the macaque RV2
rhadinoviruses, MneRV2 and RRV, were 62% identical. TheAs with homologs from other primate and murine rhadinoviruses. (A) RV1 Old
g-tailed macaque; this study) (B) RV2 Old World primate rhadinovirus lineage:
(C) New World primate rhadinoviruses: HVS (squirrel monkey; NP_040275),
e; NP_044913).
Fig. 2. Amino acid sequence comparison of the RFHVMn and MneRV2 ORF73 LANAs with homologs from other primate and murine rhadinoviruses. Protein
alignment of the rhadinovirus ORF73 homologs listed in the legend to Fig. 1. Shaded residues indicate amino acid sequence conservation: (Black)—conserved in both
RV1 and RV2 OldWorld primate rhadinoviruses, KSHV, RFHVMm, RRVand MneRV2; (Blue)—conserved in both human and macaque RV1 rhadinoviruses, KSHV
and RFHVMn; (Yellow)—conserved in both macaque RV2 rhadinoviruses, RRVandMneRV2; (Green)—conserved in both the human RV1 rhadinovirus, KSHV, and
either macaque RV2 rhadinovirus, MneRV2 or RRV; (Red)–conserved in the macaque RV1 rhadinovirus, RFHVMn, and either macaque RV2 rhadinovirus, MneRV2
or RRV. Amino acid sequences of the internal acidic repeat domains indicated as black boxes are provided in Fig. 3.
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Fig. 3. Comparison of the internal acidic repeat domains of RFHVMn LANAwith repeat domains of other rhadinoviruses. The amino acid sequences are given for the
internal acidic repeat domains of the human KSHV LANA (A) (1162-aa isolate) and macaque RFHVMn LANA (B) (1071 aa, this study) RV1 rhadinoviruses and the
squirrel monkey HVS (C) and spider monkey AtHV3 (D) New World primate rhadinoviruses (for accession numbers, see legend to Fig. 2). The four major repeat
subregions within the KSHV LANA repeat domain (1162-aa variant) are shown. The consensus amino acid and nucleotide repeat elements are indicated. Duplications
of identical sequences containing multiple consensus repeat elements in the RFHVMn sequence are indicated by single and double underlining.
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and like the analogous regions in the RFHVMn and KSHV
sequences contained a number of basic amino acids (Fig. 2).
The MneRV2 and RRV LANAs also contained a serine- and
proline-rich region (aa 47–242, MneRV2) which was 51%
conserved and analogous to those seen in RFHVMn and KSHV
(Fig. 2). While the serine–proline-rich regions of the RRV and
MneRV2 LANAs were 25–26% identical to the corresponding
region in RFHVMn LANA, these regions were less than 20%
conserved with KSHV LANA. The C-terminal region of
MneRV2 LANA (aa 295–438) was strongly conserved with
the corresponding region in RRV LANA (88% sequence
identity), but only moderately conserved with RFHVMn and
KSHV LANAs (33–35% sequence identity).
Comparison of the RFHVMn and MneRV2 LANAs with ORF73
homologs of more distantly related rhadinoviruses
ORF73 homologs have been identified in several primate
and non-primate rhadinoviruses, including the New World
monkey rhadinoviruses, HVS and AtHV3 (ateline herpesvirus
3), and the murine rhadinovirus, MHV68. The ORF73
homologs of these rhadinoviruses contain an N-terminal basic
amino-acid-rich region and a conserved C-terminal domain, as
seen in the Old World primate rhadinoviruses (Figs. 1 and 2).The C-terminal domains of the New World primate rhadino-
viruses were more strongly conserved with those of the RV2
macaque rhadinoviruses (34–35% identity) than with those of
the RV1 macaque or human rhadinoviruses (25–27%). Both
New World primate ORF73 homologs lacked a domain
homologous to the ∼200 amino acid serine–proline-rich N-
terminal domain present in all Old World primate LANA
homologs, making these proteins significantly smaller than
RFHVMn LANA (407/447 aa vs. 1071 aa) (Figs. 1 and 2). Both
New World primate ORF73 homologs contained internal
acidic repeat regions, which were, however, smaller than those
found in RFHVMn and KSHV (∼170 vs. 513 and 602 aa,
respectively; Figs. 3C and D). No similarity was detected
between the internal acidic repeats of HVS and AtHV3, nor was
there similarity with the RFHVMn and KSHV repeats at the
level of either the amino acid repeat motifs or the consensus
DNA elements encoding the repeats (Fig. 3). The murine
MHV68 ORF73 homolog was smaller than all of the other
rhadinovirus homologs, with only 314 aa (Figs. 1 and 2). While
the MHV68 ORF73 contained a conserved C-terminal domain
and a small N-terminal serine–proline-rich domain, these
domains were the least conserved with RFHVMn, MneRV2
and the other rhadinovirus ORF73 homologs. MHV68 ORF73,
like the macaque RV2 rhadinovirus ORF73 homologs, lacked
an internal acidic repeat region.
Fig. 4. Western blot analysis of COS-7 expressed recombinant RFHVMn LANA. Plasmid DNA was transfected into COS-7 cells and expressed proteins were
harvested after 18 h, resolved by SDS-PAGE and immunoblotted with either the mAB247 anti-EP monoclonal antibody (lanes A–D), the LN53 anti-KSHV LANA
monoclonal antibody (lanes E–H), or the Living Colors anti-EGFP antisera (lanes I–K). (pCDNA3/RFHV ORF73 (lanes A, E); pCDNA3/KSHV ORF73 (lanes B, F);
pEGFP/RRV ORF73 (lanes C, G, I); pEGFP/MneRV2 ORF73 (lanes D, H, J); and pEGFP control plasmid (lane K)) Arrows indicate the positions of the positive
LANA protein bands and their estimated molecular weights.
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RFHVMn LANA
Sequence analysis of RFHVMn LANA revealed the
presence of a large internal acidic repeat domain which
contained multiple repetitions of the consensus sequence
“EEPEPEPE” (Fig. 3B). A BLAST search of the NCBI protein
database revealed a close similarity between the RFHVMn
acidic repeat and an “EPEPEP” repeat found in the Trypano-
some brucei procyclin against which a monoclonal antibody
(mAB247) had been developed (Richardson et al., 1988). In
order to determine whether the anti-EP antibody would react
with the RFHVMn LANA, we cloned the RFHVMn orf73 gene
into the mammalian expression vector pCDNA3 to produce
recombinant LANA. For controls, the MneRV2 and RRV orf73
genes were cloned into the pEGFP vector to produce ORF73
fusions with the enhanced green fluorescent protein (EGFP) at
the C-terminus to permit detection. In addition, a pCDNA3
expression vector containing the KSHV LANA gene was
obtained that has been described previously (Renne et al.,
2001). The LANA expression vectors were transfected into
COS-7 cells. Western analysis of the expressed proteins
revealed a strong reactivity between the anti-EP monoclonal
antibody and a protein of approximately 240 kDa in the COS
cells transfected with the pCDNA3/RFHV LANA construct
(Fig. 4, lane A). Even though the predicted molecular weight of
the RFHVMn LANAwas approximately 118 kDa, the 240-kDa
band was similar in size to the 220- to 234-kDa KSHV LANA
which is known to migrate abnormally in SDS-PAGE (Rainbow
et al., 1997). No reactivity was detected to proteins in the COS
cells transfected with either the pCDNA3/KSHV LANA or the
pEGFP/RRV or pEGFP/MneRV2 LANA fusion proteins (Fig.
4, lanes B–D). The presence of RRVand MneRV2 LANA in the
transfected cells was demonstrated by reactivity with the anti-
EGFP Living Colors antibody. The anti-EGFP antibody reactedFig. 5. Immunofluorescence localization of recombinant RFHVMn LANA in transfec
cells were fixed, permeabilized, and incubated with Topro-3 DNA stain to detect nucl
antibody to detect the LANA proteins. Antibody-bound proteins were visualized using
visualized as green fluorescence. Inserts contain the merged Topro-3 and antibody i
pCDNA3/RFHV ORF73, pCDNA3/KSHV ORF73, pEGFP/RRV ORF73, pEGFP/Mwith a 95-kDa protein in cells transfected with the RRV-EGFP
construct (Fig. 4, lane I) and a 90-kDa doublet in cells
transfected with the MneRV2-EGFP construct which was 10
amino acids smaller than the RRV-EGFP (Fig. 4, lane J).
Several proteolytic degredation fragments were also observed,
as has been noted for EGFP fusion proteins of KSHV LANA
(Piolot et al., 2001). As a control, the anti-EGFP antibody also
reacted with the 25-kDa EGFP fusion partner (Fig. 4, lane K).
Previous studies have shown that Flag-tagged RRV LANA
migrated as a 70-kDa doublet (DeWire and Damania, 2005)
which is compatible with the size of RRV LANAwithin the 95-
kDa LANA/EGFP fusion protein produced in our transfected
cells.
We also tested the ability of recombinant RFHVMn LANA
to react with the LN53 monoclonal antibody developed against
KSHV LANA. This antibody reacts with a glutamic-acid-rich
repeat “EQEQE” in the internal acidic repeat region of KSHV
LANA (Kellam et al., 1999). Western analysis displayed a
strong reactivity of the anti-KSHV LANA antibody with a 240-
kDa doublet in the COS cells transfected with the pCDNA3/
RFHV LANA construct (1071-aa protein) (Fig. 4, lane E).
Similar reactivity was seen with a slightly smaller 220-kDa
doublet in cells transfected with the KSHV ORF73 construct
(1003-aa protein) (Fig. 4, lane F). No reactivity was detected
with the MneRV2 and RRV LANA-EGFP fusion proteins (Fig.
4, lanes G and H).
RFHVMn and MneRV2 LANA proteins localize to the cell
nucleus
To determine whether the RFHVMn and MneRV2 LANA
proteins localize to the cell nucleus, as seen with KSHV
LANA, the expression constructs for RFHVMn and KSHV
LANA proteins, and the RRV and MneRV2 LANA-EGFP
fusion proteins were transfected into COS-7 cells. After 12 h,ted COS-7 cells. Plasmid DNAwas transfected into COS-7 cells. After 12 h, the
ei (Blue) and either (A) the anti-EP antibody or (B) the LN53 anti-KSHV LANA
a red fluorescent secondary antibody while the GFP-tagged LANA fusions were
mmunofluorescence images of magnified cells. Transfected plasmids included,
neRV2 ORF73 and the pEGFP control. Arrows indicate positive cell nuclei.
Fig. 5.
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transfected with pCDNA3/RFHV ORF73, a strong immuno-
fluorescence signal was detected with the anti-EP antibody in
approximately 40% of the cells (Fig. 5A). The anti-EP
immunofluorescence signal was confined to the nucleus and
co-localized with the Topro-3 DNA fluorescence (Fig. 5A,Fig. 6. Immunohistochemical localization of RFHVMn LANA in RF tumor
biopsies. 5-μm sections of paraffin-embedded RF tumor (panels A, B) and
normal jejunum (panels C, D) tissues were deparaffinized, subjected to antigen-
retrieval, incubated with the LN53 anti-KSHV LANA monoclonal antibody
(panels A and C) or the anti-EP monoclonal antibody (panels B and D), and
finally counterstained with hematoxylin. Inserts in panels A and B show
magnification of positive nuclei recognized by the monoclonal antibodies.
110 K.L. Burnside et al. / Virology 354 (2006) 103–115insert). An obvious speckled pattern of immunofluorescence
was detected with an absence of staining in the nucleoli. The
anti-KSHV LANA monoclonal antibody gave a strong nuclear
immunofluorescence signal in the pCDNA3/RFHV ORF73
transfected cells (Fig. 5B), confirming the reactivity of this
antibody with RFHVMn LANA in Western analysis. This
fluorescence also exhibited a speckled pattern which was
absent from the nucleoli (Fig. 5B, insert). In the cells
transfected with the pCDNA3/KSHV ORF73, no staining
was detected with the anti-EP antibody (Fig. 5A), while a
strong nuclear staining was detected with the LN53 anti-
KSHV LANA antibody, as expected (Fig. 5B). These cells
also showed a speckled pattern of immunofluorescence and a
lack of nucleolar staining. No staining was apparent with
either the anti-EP or LN53 anti-KSHV LANA antibodies in
the cells transfected with the pEGFP/MneRV2 or pEGFP/RRV
LANA constructs. The presence of the RRV and MneRV2
LANA-EGFP fusion proteins in these transfected cells was
demonstrated by the presence of EGFP fluorescence confined
to the nucleus (Figs. 5A and B). Cells transfected with the
pEGFP vector alone showed staining throughout the cell
demonstrating that the LANA portion of the LANA/EGFP
fusion protein was responsible for the nuclear localization
(Figs. 5A and B). These studies confirmed the antibody
reactivity seen in our Western blot analysis.
Expression of RFHVMn LANA in the nucleus of RF tumor cells
We have previously detected RFHV DNA in RF and SF
tumor lesions (Rose et al., 1997; Schultz et al., 2000). In order to
determine whether RFHVMn LANA was expressed in the
tumor cells of RF lesions, the anti-EP and anti-KSHV LANA
monoclonal antibodies were reacted with formalin-fixed
paraffin-embedded sections of RF tumor lesions. The LN53
anti-KSHV LANA antibody showed strong staining of the
spindeloid tumor cells present in the RF lesion (Fig. 6A). This
staining was confined to the nuclei of the tumor cells (see inset).
No staining was detected in normal cells adjacent to the RF
tumor nor was staining observed in normal cells in the jejunem
of a non-affected macaque (Fig. 6C). The anti-EP monoclonal
antibody also showed intense staining of the nuclei of the
spindloid RF tumor cells (Fig. 6B and inset), replicating that
seen with the LN53 antibody. No reactivity was seen with
normal cells adjacent to the RF tumor nor with cells present in
jejunem of a non-affected macaque with the anti-EP antibody
(Fig. 6D). Histological and morphological similarities have
previously been noted between the spindle-shaped tumor cells
in RF lesions and those detected in KS lesions (London et al.,
1983; Tsai et al., 1985; Bielefeldt-Ohmann et al., 2005). Our
results demonstrate a strong similarity between the anti-LANA
antibody staining of the nuclei of the spindloid tumor cells of RF
lesions and that seen in KS lesions (Rainbow et al., 1997).
Discussion
In the current study, we cloned and sequenced the ORF73
LANA homologs of the RV1 and RV2 rhadinoviruses infectingthe pig-tailed macaque, RFHVMn and MneRV2, respectively.
Analysis of RFHVMn LANA revealed a close similarity in size
and structure to KSHV LANA. RFHVMn LANA contained the
three distinct domains that have previously been identified in
KSHV LANA, including a serine–proline-rich N-terminal
domain initiated by a region of basic amino acids, a large
highly acidic internal repeat region, and a conserved C-terminal
domain (Russo et al., 1996). The 1071-amino-acid RFHVMn
LANA, with a predicted molecular weight of approximately
118 kDa, resolved on SDS-PAGE as a 240-kDa protein that
variably migrated as a doublet (Fig. 4). This is similar to the
anomalous migration observed with KSHV LANAwhich has a
predicted molecular weight of 116–135 kDa but migrates in
SDS-PAGE as a doublet of 220–234 kDa. The migration of
RFHVMn LANA may be affected by the presence of the
internal acidic repeat region, as has been suggested for KSHV
LANA (Rainbow et al., 1997).
Analysis of MneRV2 LANA revealed a close similarity in
structure and sequence to the LANA of the closely related
rhesus macaque RV2 rhadinovirus, RRV. Both proteins
contained a serine–proline-rich N-terminal domain of approxi-
mately 250 amino acids, initiated with a basic amino-acid-rich
region, and a C-terminal domain of approximately 200 amino
acids which was highly conserved between the two sequences
(88% identical amino acids). Although the N- and C-terminal
domains were similar to those seen in RFHVMn and KSHV,
neither of the macaque RV2 rhadinovirus LANA homologs
contained the large internal acidic repeat region characteristic of
the RV1 rhadinovirus LANA homologs.
The serine–proline-rich N-terminal domains of RFHVMn
and KSHV LANA showed little sequence similarity except for
the presence of serine and proline residues. Only the
corresponding domains in the closely related RV2 rhadino-
viruses, RRV and MneRV2, had a significant sequence
similarity beyond the proline and serine residues, with 51%
conserved amino acids. Interestingly, in this region, the
RFHVMn sequence was as closely related to the two macaque
RV2 rhadinoviruses (25–26% identity) as it was to the KSHV
homolog (25% identity) (see residues shaded in red, Fig. 2).
Since the N-terminal domain of KSHV LANA is known to
interact with the host chromatin, the sequences conserved in the
macaque RV1 and RV2 rhadinoviruses may be important for
interacting with macaque chromatin.
The C-terminal domains of all the rhadinovirus LANA
homologs showed the strongest cross-sequence homology. The
LANA sequences of the two macaque RV2 rhadinoviruses,
MneRV2 and RRV, were 88% identical in this region, while the
macaque and human RV1 rhadinoviruses, RFHVMn and
KSHV, were 51% identical. The RV2 C-terminal sequences
were as similar to the New World primate rhadinovirus ORF73
sequences as they were to the RV1 sequences (∼35% in both
cases). A number of functionalities have been assigned to the C-
terminal domain of KSHV LANA, including dimerization,
transcriptional activation and repression, inactivation of cell
cycle regulatory proteins, binding to nuclear heterochromatin
(An et al., 2005; Lan et al., 2005; Mattsson et al., 2002; Platt et
al., 1999; Radkov et al., 2000; Schwam et al., 2000; Viejo-
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the KSHV genome (Cotter et al., 2001). Some of these
functionalities have also been identified in the LANA
homologs of RRV (DeWire and Damania, 2005) and HVS
(Borah et al., 2004; Verma and Robertson, 2003) supporting a
conservation of structure and function, even with the more
distantly related proteins. Further studies will reveal the
extent of the functional similarities between the RFHVMn
and KSHV LANA homologs.
The most striking structural resemblance between KSHVand
RFHVMn LANA was the presence of the large internal acidic
repeat domains (see Figs. 1 and 3). In the RFHVMn isolate
sequenced, this repeat domain was approximately 513 amino
acids in length. This is similar to the size of the repeat domain in
KSHV LANA which varies from 416–602 amino acids in
different KSHV isolates (Gao et al., 1999). The KSHV repeat
region consists of at least four separate repeat elements with
consensus sequences of “EEDD/EEED”, “QQQEP/QQREP”,
“QQQDE/QEQQDE”, and “QEQELEE/EEQEEQELEEV”
where the number and exact make-up of these domains varied
between isolates (see Fig. 3A). The RFHVMn repeat, however,
consisted almost entirely of a single consensus element
“EEPEPEPE”. This consensus sequence and some minor
variants were repeated approximately 57 times (Fig. 3B). This
suggests that the 513-amino-acid repeat domain evolved
through both short range and long range duplication events.
No obvious sequence similarity was observed between the
KSHV and RFHVMn LANA repeat domains, other than the
presence of a large number of glutamic acid residues. Although
the origin and evolution of the internal repeat domains within
the KSHV and RFHVMn LANA homologs appear to be
distinct, it is of interest that the size of the domains are quite
similar. Internal acidic repeat domains have been identified in
the LANA homologs of the NewWorld primate rhadinoviruses,
however, these domains were much smaller (<200 amino acids)
(Fig. 3), and showed no homology to the repeats of RFHVMn or
KSHV, except for the presence of acidic amino acids.
The presence of similarly sized large internal acidic repeat
regions within the LANA homologs of RFHVMn and KSHV is
suggestive of a shared structure and function. While no function
has yet been associated with the repeat region within KSHV
LANA, it has been suggested that it could participate in the
control of euchromatin/heterochromatin transition through
facilitating the opening of closed heterochromatic areas via its
large acidic structure (Szekely et al., 1999). Repeating patterns
of glutamic acid and proline residues, as seen within the
RFHVMn LANA internal repeat, have been identified in other
proteins. The trypanosome procyclin, for example, has a small
domain containing approximately 30 “EP” repeats which is
reactive with the mAB247 anti-EP monoclonal antibody
(Richardson et al., 1988). Molecular modeling and nuclear
magnetic resonance studies have indicated that glutamic acid–
proline dipeptide repeats have an extended rod-like structure
(Evans et al., 1986), and it was hypothesized that the “EP”
repeats in the procyclin provide it with a highly extended
structure important for its function as a major surface
glycoprotein (Roditi et al., 1989). Although the consensusglutamic acid–proline repeat “EEPEPEPE” in RFHVMn LANA
is a variant of the dipeptide repeat, a similar extended structure
could be important for tethering the RFHVMn episome to host
cell chromatin and participating in chromatin remodeling.
We found that the mAB247 monoclonal antibody which
recognizes the dipeptide “EP” repeats of the trypanosome
procyclin (Richardson et al., 1988) also reacts with “EP” repeats
within the recombinant RFHVMn LANA in both Western and
immunofluorescence analysis (see Figs. 4A and 5A). This
reactivity is specific given that neither MneRV2, RRV nor
KSHV LANA sequences are recognized in similar assays. We
also found that the LN53 anti-KSHV LANA monoclonal
antibody which recognizes the “EQEQE” epitope in the KSHV
LANA repeat region (Kellam et al., 1999) also reacts with
RFHVMn LANA (see Figs. 4E and 5B). This reactivity is
specific for RFHVMn LANA, as the antibody does not
recognize either of the MneRV2 and RRV LANA homologs
in both Western and immunofluorescence assays. Sequence
analysis revealed that RFHVMn LANA lacked the repeated
“EQEQE” epitopes recognized by the LN53 monoclonal
antibody. Given the presence of multiple iterations of the
sequence “EPEPE” within the RFHVMn internal repeat, this
monoclonal antibody may recognize a structural motif based on
the repetitive glutamic acid residues. Since the anti-EP
monoclonal does not react with the KSHV LANA repeats, the
reactive epitopes of the anti-EP and LN53 anti-KSHV LANA
antibodies appear to be different.
Our studies demonstrated that KSHV, RFHVMn, MneRV2
and RRV LANA recombinant proteins associated with the cell
nucleus when expressed from plasmids transfected into COS
cells. This was true for RFHVMn LANA, and for MneRV2 and
RRV LANA which were expressed as N-terminal fusions with
EGFP (see Fig. 5). We have also shown that RFHVMn LANA
localized to the nucleus of spindloid tumor cells in macaque RF
lesions using the LN53 anti-KSHV LANA and mAB247 anti-
EP monoclonal antibodies (Figs. 6A and B). The nuclear
localization signal for KSHV LANA has been localized to a
region of basic amino acids “RKRNRSP” (aa 24–30) (Piolot et
al., 2001). This sequence has similarity with nuclear localization
signals of other proteins, such as EBNA1 of EBV (eKRpRSP)
(Ambinder et al., 1991). A comparison of the aligned RFHVMn
LANA sequence at this position, i.e., aa 24–30, revealed
minimal similarities, with conservation of only three of the
seven amino acids (tKRclpP). Even less conservation was
evident with the aligned sequences of RRV and MneRV2 (aa
22–28-“Rghcahg” and “RgRcahg”, respectively). A previous
study demonstrated that the N-terminal domain of RRV (aa 1–
25), which is highly conserved with the MneRV2 sequence
(22/25 identical residues) induced nuclear localization of red
fluorescent protein (DeWire and Damania, 2005), suggesting
that this region contained a functional NLS. Using a software
program to predict putative NLSs we identified a putative NLS
sequence within RFHVMn that spanned aa 41–47 and
encoded the highly basic “ARKRRKG” motif. Further studies
to determine the sequences necessary to mediate nuclear
localization of RFHVMn, as well as MneRV2 and RRV
LANA are ongoing.
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we have shown that RFHVMn LANA is a highly expressed
nuclear antigen in the spindle-shaped tumor cells in RF lesions
of macaques with SAIDS-RF (Figs. 6A and B). RF and the
closely related subcutaneous fibromatosis (SF) are progressive
fibrovascular proliferations with morphological and histologi-
cal similarities to KS lesions (London et al., 1983; Tsai et al.,
1990). The neoplastic lesions of RF/SF and KS are multifocal
and contain characteristic spindle-shaped tumor cells. While
the KS spindle cells are of endothelial origin and carry
lymphatic markers, the exact nature and origin of the RF/SF
spindle cells are still in question (Bielefeldt-Ohmann et al.,
2005). However, the expression and localization of the
RFHVMn and KSHV LANA in the nuclei of the spindle
tumor cells are a common feature of these two related diseases.
Functional analysis of KSHV LANA has demonstrated that it
plays a role in tethering the KSHV genome to host chromatin in
the infected cells and functions to maintain viral latency by
suppressing the lytic program of virus replication, stimulating
host cell proliferation, interfering with cellular tumor suppres-
sor functions and blocking proapoptotic pathways (Ballestas et
al., 1999; Friborg et al., 1999; Krithivas et al., 2000; Lan et al.,
2004; Radkov et al., 2000). The close structural similarity
between RFHVMn and KSHV LANA and their common
presence in the nuclei of infected spindle tumor cells suggests
that RFHVMn LANA, like KSHV LANA, may play an
important role in maintaining viral latency and inducing
cellular proliferation.
In conclusion, we have identified and characterized the
ORF73 LANA homologs of the macaque RV1 and RV2
rhadinoviruses, RFHVMn and MneRV2, respectively. Our
studies have shown that RFHVMn LANA is the closest
known structural homolog of KSHV LANA, and like KSHV
LANA, is a nuclear antigen which is highly expressed in
virus-infected tumor cells. The functional comparison of
RFHVMn and KSHV LANA and the exploitation of their
structural similarities may provide an important approach for
establishing the role these proteins play in viral latency,
pathogenicity and pathogenesis of the virus-associated neo-
plastic lesions.
Materials and methods
Cells
The COS-7 African green monkey fibroblast cell line was
obtained from the ATCC, while the rhesus primary fetal
fibroblast (RPFF) cell line was a kind gift of M. Axthelm,
Oregon National Primate Research Center (ONPRC). Cells
were cultured in DMEM complete medium at 37 °C (DMEM
with 10% Cosmic-Calf Serum (Hyclone), 100 U/ml penicillin,
100 μg/ml streptomycin, 1 mM HEPES).
Rhadinovirus isolates
An isolate of the rhesus macaque RV2 rhadinovirus, RRV
strain 17577, was kindly provided by M. Axthelm and S. Wong(ONPRC). We have previously obtained an isolate of the pig-
tailed macaque RV2 rhadinovirus, MneRV2 from a naturally
infected pig-tailed macaque (M. nemestrina) (J97167) at the
WaNPRC (Bruce et al., 2005).
Tissues
RF tissues for cloning studies were obtained from a simian
retrovirus-2 (SRV-2) positive pig-tailed macaque (M78114)
with SAIDS-RF (animal 2 in Tsai et al., 1985). RF tissues for
immunohistochemistry were obtained from a 5.4-year-old SRV-
2 negative male pig-tailed macaque (K99174) which was
experimentally infected with SIV. This animal had two
neoplastic masses in the distal jejunum, which on histology
were diagnosed as RF.
Cloning and sequence analysis of RFHVMn LANA
High molecular weight DNA was isolated from an archived
frozen RF tumor lesion and used to construct a MboI-partial
genomic DNA library in lambda DASH-II vector (Stratagene).
A lambda clone containing the RFHVMn orf73 gene was
identified using a PCR-based screening technique, essentially as
described in (Bloem and Yu, 1990). This clone contained a
region of the RFHVMn genome that included the open reading
frames RF13, 72, 73, RF14 and 75. The sequence of the
RFHVMn orf73 gene was determined and deposited in
Genbank with accession number 816131.
PCR amplification and sequence analysis of MneRV2 LANA
The orf73 coding sequences for MneRV2 were identified
using a consensus-degenerate hybrid oligonucleotide (CODE-
HOP) PCR approach, essentially as described in Rose et al.
(2003). DNA isolated from RPFF cells infected with the
MneRV2 rhadinovirus isolate (J97167) was used as template.
The complete sequence of the orf73 LANA, N14 and orf72
flanking sequences were obtained and the MneRV2 orf73
sequence was deposited in Genbank with accession number
824200.
Sequence analysis
The sequences of the LANA homologs from KSHV, RRV,
MneRV2 and RFHVMn were multiply aligned using Clus-
talW. In order to identify possible nuclear localization
sequences, the LANA sequences were analyzed using the
web-based “predictNLS” program (http://cubic.bioc.columbia.
edu/predictNLS).
Construction of LANA expression vectors
The RFHVMn orf73 coding sequences and 117 bp of 5′ non-
coding sequence were cloned into pCDNA3 (Invitrogen)
yielding the expression plasmid, pCDNA3/RFHV ORF73.
The MneRV2 and RRV orf73 coding sequences including 22 bp
and 17 bp of 5′ non-coding sequences, respectively, were
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plasmids pEGFP/MneRV2 ORF73 and pEGFP/RRV ORF73
producing ORF73-EGFP fusion proteins. The KSHV
pCDNA3.1 V5/HISA orf73 (pCDNA3/KSHV ORF73) encod-
ing the 1003-aa KSHV LANAwas a kind gift from Rolf Renne,
and has been described previously (Renne et al., 2001).
Transfections
COS-7 cells were transfected with either the pEGFP (vector
control), pEGFP/MneRV2 ORF73, pEGFP/RRV ORF73,
pCDNA3/RFHV ORF73, or pCDNA3/KSHV ORF73 vector
using Transit LT-1 (Mirus). Cells were incubated at 37 °C and
either processed for immunofluorescence after 11–24 h or
harvested for SDS-PAGE/Western analysis. For immunofluor-
escence, the cells were first analyzed on an inverted
fluorescence microscope for EGFP expression and then fixed
with 8% paraformaldehyde for subsequent immunofluorescence
processing and Topro-3 staining.
Antibody reagents
The rat monoclonal LN53 antibody, reactive with the
“EQEQE” epitope of the KSHV ORF73 LANA protein (Kellam
et al., 1999), was purchased from ABI Advanced Biotechnol-
ogies, Columbia, MD. The mouse monoclonal mAB247,
reactive with the “EP” repeat of the T. brucei procyclin
(Richardson et al., 1988), was a kind gift of Terry Pearson,
University of Victoria, Canada. The rabbit anti-EGFP Living
Colors antibody was purchased from Clontech. Secondary
antibody reagents included alkaline phosphatase-labeled goat
antibodies against rabbit (Promega), rat (Biosource), and mouse
IgG (Promega), Alexa 594 (red) fluorescent-labeled goat
antibodies against mouse(rat) IgG (Molecular Probes), and
biotinylated goat antibodies against rat and mouse IgG (Vector
Laboratories).
Western analysis
Transfected cells were solubilized and the proteins were
resolved on SDS-PAGE (Invitrogen) and transferred to
nitrocellulose membranes. The membranes were incubated
with either the LN53 anti-KSHV LANA antibody (1:1000), the
mAB 247 anti-EP antibody (1:100), or the Living colors anti-
EGFP antibody (1:1000). The membranes were then incubated
with alkaline phosphatase-labeled goat anti-immunoglobulin
antibodies. The proteins were visualized with 5-Bromo-4-
Chloro-3-Indolylphosphate/Nitro Blue Tetrazolium (BCIP/
NBT) Liquid Substrate System (Sigma). The Precision Plus
Protein Dual Color standard (Bio-Rad) was used for molecular
weight estimation.
Immunofluorescence assays
The COS-7 cells transfected with the different LANA
expression vectors were fixed, permeabilized and reacted
with either the LN53 anti-KSHV LANA antibody (1:1000)or the mAB247 anti-EP antibody (1:40) diluted in Blocker.
Bound immunoglobulins were detected with fluorescent
labeled goat anti-mouse(rat) IgG. Nuclear DNA was
visualized with Topro-3 (1:500) (Molecular Probes). The
cells were analyzed using a confocal fluorescent microscope
(Zeiss).
Immunohistochemistry
Tissue sections were deparaffinized and subjected to antigen-
retrieval by boiling in 0.1mM EDTA, pH 8.0, for 15 min. The
sections were incubated with the LN53 anti-KSHV LANA
antibody or the mAB247 anti-EP antibody and bound antibody
was visualized with biotinylated anti-immunoglobulin antibody
and avidin–biotin–horseradish-peroxidase conjugates (Vector
Laboratories) with diamino-benzidine or 3-amino-9-ethyl-
carbazole as the chromogen. Sections were counterstained
with Harry's hematoxylin and examined in a Nikon Eclipse
E600 microscope. Microphotographs were taken using a Nikon
Coolpix 4500 camera and prepared for publication using Adobe
Photoshop CS.
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